BioCentury
ARTICLE | Company News

Theranostics Health, Avant Diagnostics deal

May 30, 2016 7:00 AM UTC

Avant acquired fellow diagnostic company Theranostics Health for 25 million shares of Avant valued at $8 million based on Avant’s close of $0.32 on May 11, the day before the deal was announced. Thera...